CMNDNasdaqPharmaceutical Preparations

Clearmind Medicine Inc. (CMND) earnings date, market-implied expected move, and options open interest by expiry

5.86

−0.06 · −1.01%

Regular session12:04 ET

Open5.85Volume1,915Mkt cap$9,880

Day5.85 – 5.86100%52-wk5.25 – 2,688.000%

CMND

Clearmind Medicine Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

8dClearmind completes recruitment for AUD CMND-100 cohorts: two 6‑patient 80 mg, 160 mg
32dCMND trading halt (T3) · resumed 09:00 ET
57dClearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

News

Next report

Last report

—

Largest filed tie

—

13F top-10 QoQ

—

Top fund weight

—

No upcoming report date for Clearmind Medicine (CMND). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 12:00 ET

Intraday

Event sensitivity

NFP ×1.87· ±9.5% vs ±5.1% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±9.5%3 of 10×1.87

PPIproducer prices±8.3%3 of 10×1.62

CPIconsumer prices±5.2%5 of 10×1.02

FOMCrate decision±3.9%9 of 24×0.76

GDPgross domestic product±3.3%7 of 19×0.64

CPROFcorporate profits±3.2%4 of 12×0.62

PCEpersonal income & outlays±2.9%9 of 19×0.58

Bar = avg |move| to ±10% · tick = ±5.1% avg day · ×base = |move| ÷ ±5.1% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod